Trial intelligence / Profile preview

QLB vs TAPB for Postoperative Analgesia in Midline Laparotomy

NCT06950502Completed

Sponsor
Ankara University
Start
Mar 2022
Primary completion
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Ankara University. Primary endpoint: Total morphine consumption in the first 24 hours postoperatively. Started Mar 2022; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06950502.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06950502.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call